SMAD3 and atherosclerosis: It is well-known that high levels of cholesterol are a risk factor for atherosclerosis, and recently it was reported that treatment with IL-37 recombinant diminishes the accumulation of lipids and the foam cells’ formation into the atherosclerotic plaque, as regulated by the transcription factor Smad3 [29,30].